These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9823334)

  • 1. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.
    Crawford HC; Matrisian LM; Liaw L
    Cancer Res; 1998 Nov; 58(22):5206-15. PubMed ID: 9823334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
    Bourassa B; Monaghan S; Rittling SR
    Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
    Jin H; Valverde P; Chen J
    Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
    McCawley LJ; Crawford HC; King LE; Mudgett J; Matrisian LM
    Cancer Res; 2004 Oct; 64(19):6965-72. PubMed ID: 15466188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
    Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
    Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of arterial physiology in osteopontin-null mice.
    Myers DL; Harmon KJ; Lindner V; Liaw L
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1021-8. PubMed ID: 12714436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
    Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is proinflammatory in experimental autoimmune uveitis.
    Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin: possible role in prostate cancer progression.
    Thalmann GN; Sikes RA; Devoll RE; Kiefer JA; Markwalder R; Klima I; Farach-Carson CM; Studer UE; Chung LW
    Clin Cancer Res; 1999 Aug; 5(8):2271-7. PubMed ID: 10473115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
    Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Osteopontin in tumor metastasis.
    Wai PY; Kuo PC
    J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutant HA-ras gene expression in transformed murine keratinocyte lines grown under in vitro and in vivo conditions.
    Volpe JP; Conti CJ; Slaga TJ
    Mol Carcinog; 1996 Dec; 17(4):202-6. PubMed ID: 8989913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
    Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
    Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.